Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

<p>Abstract</p> <p>Background</p> <p>The current standard treatment, at least in Europe, for patients with primarily resectable tumors, consists of surgery followed by adjuvant chemotherapy. But even in this prognostic favourable group, long term survival is disappointing because of high local and d...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Roeder Falk, Timke Carmen, Saleh-Ebrahimi Ladan, Schneider Lutz, Hackert Thilo, Hartwig Werner, Kopp-Schneider Annette, Hensley Frank W, Buechler Markus W, Debus Juergen, Huber Peter E, Werner Jens
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2012-03-01
Edice:	BMC Cancer
On-line přístup:	http://www.biomedcentral.com/1471-2407/12/112
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!